Company: CERO
Filing Date: 2025-12-05
Form Type: S-1
Source: 0001213900-25-118817
Chunk: 320

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-12-05
Form: S-1
Chunk 320
---
 reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter 
 period that the issuer was required to file such reports and materials) other than Form 8-K reports; and                             |

| ● | at least one year has elapsed                                                                                                            
 from the time that the issuer filed current Form 10-type information with the SEC reflecting its status as an entity that is not a shell 
 company.                                                                                                                                 |

We are no longer a shell company and, as a result, once the conditions set forth in the exceptions listed above are satisfied, Rule 144 will become available for the resale of shares of Common Stock. Registration Rights Each of the Investor Rights Agreement, the Keystone Registration Rights Agreements, the Arena Purchase Agreement, the Fee Modification Agreements and the Liquidated Damages Modification Agreement provides for certain registration rights. For additional information, see the subsections entitled “ Description of Securities-Registration Rights.” 188 PLAN OF DISTRIBUTION The Common Stock offered by this prospectus are being offered by the Selling Securityholder. The shares may be sold or distributed from time to time by the Selling Securityholder directly to one or more purchasers or through brokers, dealers, or underwriters who may act solely as agents at market prices prevailing at the time of sale, at prices related to the prevailing market prices, at negotiated prices, or at fixed prices, which may be changed. The sale of our Common Stock offered by this prospectus could be effected in one or more of the following methods:

| ● | ordinary brokers’ transactions; |

| ● | transactions involving cross 
 or block trades;             |

| ● | through brokers, dealers, or               
 underwriters who may act solely as agents; |

| ● | “at the market”                               
 into an existing market for our Common Stock; |

| ● | in other ways not involving                                                                                           
 market makers or established business markets, including direct sales to purchasers or sales effected through agents; |

| ● | in privately negotiated transactions; 
 or                                    |

| ● | any combination of the foregoing. |

In order to comply with the securities laws of certain states, if applicable, the shares may be sold only through registered or licensed brokers or dealers. In addition, in certain states, the shares may not be sold unless they have been registered or qualified for sale in the state or an exemption from the state’s registration or qualification requirement is available and complied with. The Selling Securityholder is an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act.